Martingale Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Martingale Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Buy	70,360 +24,218	+52%	+$741K	0.06%	334
2026 Q1	$1.54M	Buy	+46,142	New	+$1.55M	0.04%	398
2024 Q4	–	Sell	-21,678	Closed	-$687K	–	811
2024 Q3	$687K	Sell	21,678 -15	-0.1%	-$569	0.02%	554
2024 Q2	$762K	Buy	21,693 +7,303	+51%	+$289K	0.02%	510
2024 Q1	$631K	Buy	14,390 +6,121	+74%	+$263K	0.01%	569
2023 Q4	$294K	Buy	+8,269	New	+$247K	0.01%	703

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Martingale Asset Management's IDYA Position: Q2 2026 in Review

Martingale Asset Management increased its IDEAYA Biosciences (IDYA) stake by 52% in Q2 2026, buying an estimated $741K and bringing the position to 70,360 shares worth $2.62M. The position accounts for 0.06% of the portfolio, ranked #334.

Martingale Asset Management first reported a position in IDYA in Q4 2023 and has held it in 6 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Martingale Asset Management held 70,360 shares of IDEAYA Biosciences worth $2.62M as of Q2 2026.
Martingale Asset Management bought 24,218 IDEAYA Biosciences shares in Q2 2026, an estimated $741K.
IDEAYA Biosciences made up 0.06% of Martingale Asset Management's portfolio in Q2 2026, its #334 holding.
Martingale Asset Management first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 6 quarters since.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.